首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4718篇
  免费   157篇
  国内免费   96篇
耳鼻咽喉   10篇
儿科学   73篇
妇产科学   46篇
基础医学   460篇
口腔科学   95篇
临床医学   229篇
内科学   731篇
皮肤病学   51篇
神经病学   318篇
特种医学   84篇
外国民族医学   2篇
外科学   356篇
综合类   520篇
预防医学   332篇
眼科学   59篇
药学   1098篇
中国医学   293篇
肿瘤学   214篇
  2023年   45篇
  2022年   47篇
  2021年   120篇
  2020年   97篇
  2019年   231篇
  2018年   209篇
  2017年   130篇
  2016年   78篇
  2015年   68篇
  2014年   197篇
  2013年   275篇
  2012年   248篇
  2011年   332篇
  2010年   231篇
  2009年   230篇
  2008年   255篇
  2007年   282篇
  2006年   165篇
  2005年   161篇
  2004年   120篇
  2003年   110篇
  2002年   95篇
  2001年   82篇
  2000年   76篇
  1999年   79篇
  1998年   58篇
  1997年   45篇
  1996年   32篇
  1995年   49篇
  1994年   46篇
  1993年   48篇
  1992年   31篇
  1991年   24篇
  1990年   27篇
  1989年   23篇
  1988年   17篇
  1987年   16篇
  1986年   24篇
  1985年   65篇
  1984年   88篇
  1983年   51篇
  1982年   65篇
  1981年   56篇
  1980年   55篇
  1979年   42篇
  1978年   35篇
  1977年   28篇
  1976年   27篇
  1975年   19篇
  1973年   18篇
排序方式: 共有4971条查询结果,搜索用时 25 毫秒
1.
Background: The current disadvantages (high cost, toxicity, resistance) of chemotherapy for gastric cancer opted people for alternative therapy from natural source. Curcumin (natural product) possess multiple biological activities but low bio-availability limits their uses as therapeutic. The Nano-formulation of curcumin increased the bioavailability and productivity of anti-cancer and anti-bacterial properties. The present study was initiated to determine the anti-cancer and anti-bacterial effect of Nano curcumin against gastric cancer and H. pylori. Methods: Curcumin loaded PLGA nanoparticles (CUR-NPs) was prepared by single emulsion solvent evaporation method. The MIC were determined using agar dilution method to find the anti-H. Pylori activity of Nano curcumin. The cytotoxicity of Nano curcumin was evaluated by MTT assay and the apoptotic effect (cell cycle arrest and morphology change) was shown by PI staining and microscopy. Results: The MIC of nanocurcumin and curcumin for all four H. pylori strains were 8 µg/ml and 16 µg/ml respectively. The inhibition rate of gastric cancer cells after treatment with curcumin was increased from 6% to 67% for 24h, from 8% to 75% for 48h, from 10% to 83% for 72h. In case of nanocurcumin, the inhibition rate increased from 7% to 69% for 24h, 11% to 87% for 48h and 16% to 97% for 72h. The IC50 of curcumin and Nano-curcumin were 24.20 µM and 18.78 µM respectively for 72 h. The population of cells in sub-G0 population increased from 4.1% in the control group to 24.5% and 57.8% when treated with curcumin and nanocurcumin respectively. After 72h of treatment with nanocurcumin, the apoptotic cells population increased as compared to native curcumin treated cells. Conclusion: The Nano curcumin might be used as a potential therapeutics against gastric cancer and H. Pylori. There is need of further in vivo study in order to validate CUR-NPs activity.  相似文献   
2.
《Injury》2023,54(7):110767
AimThis network meta-analysis aims to compare functional outcomes and complications between conservative treatment and surgery for distal radius fractures in patients aged 60 years and over.MethodsWe searched the PubMed, EMBASE, and Web of Science databases for randomized controlled trials (RCTs) assessing the effect of conservative treatment and surgery for distal radius fractures in patients aged 60 years and over. Primary outcomes included grip strength and overall complications. Secondary outcomes included Disabilities of the Arm, Shoulder, and Hand (DASH) scores, Patient-Rated Wrist Evaluation (PRWE) scores, wrist range of motion and forearm rotation, and radiographic assessment. All continuous outcomes were assessed using standardized mean differences (SMDs) with 95% confidence intervals (CIs), and binary outcomes were assessed using odds ratio (OR) with 95% CIs. The surface under the cumulative ranking curve (SUCRA) was used to determine a hierarchy of treatments. Cluster analysis was performed for grouping treatments based on the SUCRA values of primary outcomes.ResultsFourteen RCTs were included to compare conservative treatment, volar lockedplate (VLP), K-wires fixation, and external-fixation. VLP outperformed conservative treatment for 1-year and minimum 2-year grip strength (SMD; 0.28 [0.07 to 0.48] and 0.27 [0.02 to 0.53], respectively). VLP yielded the optimal grip strength at 1-year and minimum 2-year follow-up (SUCRA; 89.8% and 86.7%, respectively). In a subgroup analysis of patients aged 60 to 80 years old, VLP outperformed conservative treatment in DASH and PRWE scores (SMD, 0.33 [0.10, 0.56] and 0.23 [0.01, 0.45], respectively). In addition, VLP had the fewest complications (SUCRA = 84.3%). Cluster analysis suggested that VLP and K-wire fixation were more effective treatment groups.ConclusionEvidence to date demonstrates that VLP provides measurable benefits in grip strength and fewer complications to those 60 years of age and over, and that benefit is not reflected in current practice guidelines. There is a subgroup of patients where K-wire fixation outcomes are similar to those of VLP; defining this subgroup may yield substantial societal benefits.  相似文献   
3.
《药学学报(英文版)》2020,10(5):799-811
Overexpression of adenosine triphosphate (ATP)-binding cassette subfamily G member 2 (ABCG2) in cancer cells is known to cause multidrug resistance (MDR), which severely limits the clinical efficacy of chemotherapy. Currently, there is no FDA-approved MDR modulator for clinical use. In this study, rociletinib (CO-1686), a mutant-selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), was found to significantly improve the efficacy of ABCG2 substrate chemotherapeutic agents in the transporter-overexpressing cancer cells in vitro and in MDR tumor xenografts in nude mice, without incurring additional toxicity. Mechanistic studies revealed that in ABCG2-overexpressing cancer cells, rociletinib inhibited ABCG2-mediated drug efflux and increased intracellular accumulation of ABCG2 probe substrates. Moreover, rociletinib, inhibited the ATPase activity, and competed with [125I] iodoarylazidoprazosin (IAAP) photolabeling of ABCG2. However, ABCG2 expression at mRNA and protein levels was not altered in the ABCG2-overexpressing cells after treatment with rociletinib. In addition, rociletinib did not inhibit EGFR downstream signaling and phosphorylation of protein kinase B (AKT) and extracellular signal-regulated kinase (ERK). Our results collectively showed that rociletinib reversed ABCG2-mediated MDR by inhibiting ABCG2 efflux function, thus increasing the cellular accumulation of the transporter substrate anticancer drugs. The findings advocated the combination use of rociletinib and other chemotherapeutic drugs in cancer patients with ABCG2-overexpressing MDR tumors.  相似文献   
4.
Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) is the fourth commonest female malignancy worldwide. CESC progresses in immune-microenvironment mainly composed of infiltrating immune and stromal cells. Here, we performed an integrated analysis incorporating the expression profiles from the Cancer Genome Atlas (TCGA) database and scores of immune and stromal cells calculated by Estimation of Stromal and Immune cells in Malignant Tumours using Expression data (ESTIMATE) algorithm. A two-gene signature (CD1C and CD6 genes) was established to predict the prognosis of CESC. Based on this signature, patients were divided into the high- and low-risk groups, and this signature showed good prognostic performance according to the results of Kaplan-Meier analysis and receiver operating characteristic (ROC) analysis in train set and two validation sets. A nomogram was built for evaluating the clinical applicability of this signature. In addition, based on Tumor Immune Estimation Resource (TIMER) database, 2 hub genes showed negative correlations with tumor purity and positive correlations with infiltrating levels of immune filtrating cells. What’s more, we propose new treatment strategies for the two prognostic subtypes. Low- risk patients were found presenting with a higher level of immune checkpoint molecules and showing higher immunogenicity in immunophenoscore (IPS) analysis, which indicated a better response for immunotherapy. Meanwhile, estimated by Genomics of Drug Sensitivity in Cancer (GDSC) database, the high-risk patients showed sensitive responses to five chemotherapy drugs. Finally, 10 candidate small-molecule drugs for CESC were defined. In summary, the CD1C-CD6 signature can accurately predict the prognosis of CESC.  相似文献   
5.
目的总结臀部筋膜脂肪瓣修复坐骨结节、大转子复发性窦道型压疮的效果。方法2018 年 2 月—2019 年 6 月,收治 12 例 13 处长期截瘫伴坐骨结节、大转子复发性窦道型压疮患者。其中男 10 例 11 处,女 2 例 2 处;年龄 46~56 岁,平均 51 岁。截瘫 10~20 年,平均 13 年;所有患者均有压疮手术史,术后 3 个月~12 年复发。其中坐骨结节处压疮 11 例,坐骨结节合并大转子处压疮 1 例。创面清创、切除窦道假性滑液囊,采用单侧或双侧臀部筋膜脂肪瓣填塞窦道,术区一期缝合闭合切口。结果术后 13 处压疮切口均Ⅰ期愈合,局部无红肿、渗液,术后 14 d 拆线出院。术后局部平坦,外观理想。术后患者均获随访,随访时间 8~24 个月,平均 14 个月。随访期间压疮均无复发。结论臀部脂肪组织丰富,利用筋膜脂肪瓣修复坐骨结节、大转子复发性窦道型压疮设计、操作简便,临床效果良好。  相似文献   
6.
IntroductionMounting evidence supports a role for estrogen signaling in NSCLC progression. We previously reported a seven-gene signature that predicts prognosis in estrogen receptor β positive (ERβ+) NSCLC. The signature defines a network comprised of ER and human EGFR-2/3 (HER2/HER3) signaling.MethodsWe tested the efficacy of combining the pan-HER inhibitor, dacomitinib, with the estrogen antagonist, fulvestrant, in ERβ+ NSCLC models with differing genotypes. We assessed the potency of this combination on xenograft growth and survival of host mice, and the ability to reverse the gene signature associated with poor outcome.ResultsSynergy was observed between dacomitinib and fulvestrant in three human ERβ+ NSCLC models: 201T (wild-type EGFR), A549 (KRAS mutant), and HCC827 (EGFR 19 deletion) with combination indices of 0.1-0.6. The combination, but not single agents, completely reversed the gene signature associated with poor prognosis in a mechanism that is largely mediated by activator protein 1 downregulation. In vivo, the combination also induced tumor regression and reversed the gene signature. In HCC827 xenografts treated with the combination, survival of mice was prolonged after therapy discontinuation, tumors that recurred were less aggressive, and two mechanisms of HER inhibitor resistance involving c-Met activation and PTEN loss were blocked.ConclusionsThe combination of an ER blocker and a pan-HER inhibitor provides synergistic efficacy in different models of ERβ+ NSCLC. Our data support the use of this combination clinically, considering its ability to induce potent antitumor effects and produce a gene signature that predicts better clinical outcomes.  相似文献   
7.
目的通过轴向应力刺激促进骨再生,观察基质细胞衍生因子 1α/趋化因子 CXC 亚族受体 4(stromal cell-derived factor 1α/cysteine X cysteine receptor 4,SDF-1α/CXCR4)信号通路变化,探讨轴向应力刺激促进骨再生的机制。方法取 72 只雄性新西兰大白兔,于右后肢胫骨近端内侧制备直径 8 mm 圆形皮质骨缺损并脱蛋白松质骨支架修复模型,随机分为 3 组(n=24)。A 组腹腔注射 PBS,B 组术肢给予应力刺激治疗+腹腔注射 PBS,C 组术肢给予应力刺激治疗+腹腔注射 CXCR4 拮抗剂(AMD3100)。术后 2、4、8、12 周,摄 X 线片并采用 Lane-Sandhu X 线评分标准评价骨愈合情况,取标本行 HE 染色观察新生骨组织及支架降解,免疫组织化学染色观察 VEGF、CXCR4 表达水平;4、8 周取标本 Western blot 检测 SDF-1α 及 CXCR4 蛋白表达水平;12 周行 Micro-CT 检查,计算新生骨体积及新生骨密度。 结果X 线片检查示,除术后 2 周各组骨缺损区及支架无明显变化外,4、8 及 12 周时 B 组骨愈合评分均高于 A、C 组(P<0.05)。12 周时 Micro-CT 扫描可见 B 组骨缺损修复、髓腔再通,新生骨体积及骨密度均高于 A、C 组(P<0.05)。HE 染色显示,术后 4 周开始 B 组骨再生及支架降解均明显快于 A、C 组。免疫组织化学染色示,各组 VEGF 及 CXCR4 阳性表达均在 4 周达峰值;各时间点 B 组 VEGF 及 CXCR4 表达量均显著高于 A、C 组(P<0.05)。Western blot 检测显示,4、8 周时 B 组 SDF-1α 与 CXCR4 表达量均显著高于 A、C 组(P<0.05)。 结论轴向应力刺激促进骨再生可能与其促进骨缺损区组织高表达 SDF-1α,激活与其下游调控 BMSCs 募集的 CXCR4 信号有关。  相似文献   
8.

Objective

The aim of the study was to assessment the impact of hip osteoarthritis on postural stability.

Methods

One hundred and twenty-five randomly selected women 20–85 years old (mean age of 49 ± 24.4 years) were assigned to three groups based on age, health status and activity level. Group 1 (cases) – elderly women with diagnosed hip osteoarthritis, group 2 (control) - women without hip osteoarthritis, and group 3 (control) - healthy young women. Assessment of postural stability were measured using a WIN-POD Pel 38 electronic podometer. Statistica 10 software was used to perform t-test resulting in significance level of p < 0.05.

Results

Significant differences in pedobarographic balance measurements were observed between the study groups with eyes opened or closed (deviation length eyes open: group 1–3 and 2–3 p < 0.0001; eyes closed group 1–2 p = 0.19; 1–3 and 2–3 p < 0.0001; deviation area eyes open: group 1-3 and 2–3 p < 0.0001; eyes closed group 1–3 and 2–3 p < 0.0001; deviation velocity eyes open: group1-3 and 2–3 p < 0.0001; eyes closed group 1–2 p < 0.010, 1–3 and 2–3 p < 0.0001). The poorest postural stability was observed in patients with hip osteoarthritis (deviation length eyes open vs eyes closed 180.8/201.7 p = 0.028, deviation area 128.7/145.7 p = 0.771, deviation velocity 5.1/6.1 p < 0.0001), and the best postural stability was observed in young women (deviation length 111.3/137.5 p < 0.0001, deviation area 57/76.9 p = 0.003, deviation velocity 3.4/4.2 p < 0.0001).

Conclusion

(1) Osteoarthritic degeneration of the hip joint results in a significant disturbance in proprioception. This finding was reflected by the inferior stability parameters collected from subjects with hip osteoarthritis when asked to stand with their eyes closed. These finding were not observed in the other groups. (2) The disorder of the body stability of people with osteoarthritis may be a relative indication for the implantation of hip arthroplasty.  相似文献   
9.
目的总结近年来股骨转子间骨折在稳定性重建方面的概念演化与研究进展。方法查阅国内外相关文献并结合自身经验,从股骨转子间骨折的解剖特点、稳定型骨折与不稳定型骨折分类、稳定性复位与不稳定性复位、术中加压初始稳定与术后滑动二次稳定、内固定术后稳定性评估、早期下地站立负重等方面进行总结分析。结果股骨转子间骨折发生于股骨颈干骺端转换区,具有天然的内翻不稳定倾向。骨折复位质量是影响后续内固定物安放的最重要前提因素。判断骨折复位质量有对线和对位两方面,对线采用 Garden 指数;在对位方面,随着皮质对位理念(正性、中性、负性)的提出,特别强调前内侧皮质的相互砥住支撑(解剖、正性),是获得骨折稳定性复位的关键,而不再强调后内侧小转子骨块的作用。术后影像学的稳定性评分为早期下地站立负重提供了量化指标。但术中的前内侧皮质支撑复位,在术后头颈骨块滑动获得二次稳定的过程中,仍有皮质对位丢失现象,需研究其危险因素和防范措施。结论股骨转子间骨折在取得良好对线的基础上,只要获得了前内侧皮质的相互砥住和支撑,并用内固定器械维持住,就获得了术后稳定性。术后稳定性评分优良者,可以安全地早期下地负重、站立行走活动。  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号